This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Gilead Sciences Inc. rose 2.8% to $109.11 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.4% to 5,940.46 and Dow Jones Industrial Average falling 0.3% to 42,677.24.
This was the stock's fourth consecutive day of gains.
Gilead Sciences Inc. closed 9.0% below its 52-week high of $119.96, which the company achieved on March 10th.
The stock outperformed some of its competitors, as Johnson & Johnson rose 0.8% to $153.66, Pfizer Inc. rose 2.3% to $23.52, and Abbott Laboratories fell 0.26% to $135.20.
Trading volume totaled 10.4 million, compared to the 50-day average of 9.8 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 20, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.